136 related articles for article (PubMed ID: 33856264)
21. Expression of hypoxia-inducible factor (HIF)-1alpha and vascular endothelial growth factor (VEGF)-D as outcome predictors in resected esophageal squamous cell carcinoma.
Tzao C; Lee SC; Tung HJ; Hsu HS; Hsu WH; Sun GH; Yu CP; Jin JS; Cheng YL
Dis Markers; 2008; 25(3):141-8. PubMed ID: 19096126
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of hypoxia inducible factor 1α in esophageal squamous cell carcinoma.
Munipalle PC; Viswanath YK; Davis PA; Scoones D
Dis Esophagus; 2011 Apr; 24(3):177-81. PubMed ID: 21073615
[TBL] [Abstract][Full Text] [Related]
23. IGF2BP1/UHRF2 Axis Mediated by miR-98-5p to Promote the Proliferation of and Inhibit the Apoptosis of Esophageal Squamous Cell Carcinoma.
Fang XY; Sun JJ; Chen SY; Wu KJ; Yu Y; Zhang C; Duan CZ
Ann Clin Lab Sci; 2021 May; 51(3):329-338. PubMed ID: 34162562
[TBL] [Abstract][Full Text] [Related]
24. Identification of key genes by integrating DNA methylation and next-generation transcriptome sequencing for esophageal squamous cell carcinoma.
Chen Y; Liao LD; Wu ZY; Yang Q; Guo JC; He JZ; Wang SH; Xu XE; Wu JY; Pan F; Lin DC; Xu LY; Li EM
Aging (Albany NY); 2020 Jan; 12(2):1332-1365. PubMed ID: 31962291
[TBL] [Abstract][Full Text] [Related]
25. HIF-1α stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/β-catenin signalling pathway.
Tang K; Toyozumi T; Murakami K; Sakata H; Kano M; Endo S; Matsumoto Y; Suito H; Takahashi M; Sekino N; Otsuka R; Kinoshita K; Hirasawa S; Hu J; Uesato M; Hayano K; Matsubara H
Br J Cancer; 2022 Aug; 127(3):474-487. PubMed ID: 35484214
[TBL] [Abstract][Full Text] [Related]
26. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma.
Yang Z; Zhang C; Feng Y; Qi W; Cui Y; Xuan Y
Exp Mol Pathol; 2019 Aug; 109():104239. PubMed ID: 30904401
[TBL] [Abstract][Full Text] [Related]
27. Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma.
Yokobori T; Bao P; Fukuchi M; Altan B; Ozawa D; Rokudai S; Bai T; Kumakura Y; Honjo H; Hara K; Sakai M; Sohda M; Miyazaki T; Ide M; Nishiyama M; Oyama T; Kuwano H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1566-73. PubMed ID: 26310281
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between the expression of hypoxia-inducible factor-1alpha and chemotherapy response in esophageal squamous cell carcinoma].
Wu XA; Sun Y; Fan QX; Wang LX; Wang RL
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1783-5. PubMed ID: 17919389
[TBL] [Abstract][Full Text] [Related]
29. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia-inducible factor (HIF)-1alpha expression.
Chen Y; Lu Y; Lu C; Zhang L
Pathol Oncol Res; 2009 Sep; 15(3):487-93. PubMed ID: 19130303
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological and prognostic significance of hypoxia-inducible factor-1α in esophageal squamous cell carcinoma: a meta-analysis.
Ping W; Sun W; Zu Y; Chen W; Fu X
Tumour Biol; 2014 May; 35(5):4401-9. PubMed ID: 24425106
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between hypoxia inducible factor-1α and esophageal squamous cell carcinoma: a meta analysis].
Jing S; Wang J; Liu Q; Cheng Y; Yang C; Wang Y; Cao F; Wen B; Jiao W; Guo Y
Zhonghua Bing Li Xue Za Zhi; 2014 Sep; 43(9):593-9. PubMed ID: 25471499
[TBL] [Abstract][Full Text] [Related]
32. Beclin-1 is a Promising Prognostic Biomarker in a Specific Esophageal Squamous Cell Carcinoma Population.
Du H; Luo F; Shi M; Che J; Zhu L; Li H; Hang J
Pathol Oncol Res; 2021; 27():594724. PubMed ID: 34257544
[TBL] [Abstract][Full Text] [Related]
33. Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer.
Yu Y; Li Z; Huang C; Fang H; Zhao F; Zhou Y; Pan X; Li Q; Zhuang Y; Chen L; Xu J; Wang W
Cancer Med; 2020 Jan; 9(2):575-585. PubMed ID: 31793228
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
35. HIF-1α siRNA and cisplatin in combination suppress tumor growth in a nude mice model of esophageal squamous cell carcinoma.
Liao HY; Wang GP; Gu LJ; Huang SH; Chen XL; Li Y; Cai SW
Asian Pac J Cancer Prev; 2012; 13(2):473-7. PubMed ID: 22524809
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of UBE2C in esophageal squamous cell carcinoma tissues and molecular analysis.
Li R; Pang XF; Huang ZG; Yang LH; Peng ZG; Ma J; He RQ
BMC Cancer; 2021 Sep; 21(1):996. PubMed ID: 34488675
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive bioinformatics analysis identifies lncRNA HCG22 as a migration inhibitor in esophageal squamous cell carcinoma.
Li X; Xiao X; Chang R; Zhang C
J Cell Biochem; 2020 Jan; 121(1):468-481. PubMed ID: 31236983
[TBL] [Abstract][Full Text] [Related]
39. piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B.
Su JF; Zhao F; Gao ZW; Hou YJ; Li YY; Duan LJ; Lun SM; Yang HJ; Li JK; Dai NT; Shen FF; Zhou FY
Pathol Res Pract; 2020 Apr; 216(4):152848. PubMed ID: 32051106
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
